Sweeping DOJ Reorganization Sparks Controversy and Concerns
The U.S. Justice Department is undergoing its most extensive reorganization in two decades, affecting drug enforcement and racial mediation offices. Critics, including congressional Democrats and former DOJ staff, argue the changes might hinder vital functions. The reorganization aims to save $11 million and aligns with President Trump's agenda for efficient governance.

The U.S. Justice Department is set to undergo its most extensive reorganization in two decades. The overhaul includes closing a task force targeting drug cartels and an office dedicated to easing racial tensions. Attorney General Pam Bondi approved the plan, which is projected to cut about 275 positions.
The changes are designed to increase efficiency and governance, with the DOJ stating that they will save over $11 million as part of President Trump's mission for a more effective government. However, the plan has drawn significant criticism, particularly from congressional Democrats.
Critics argue that crucial functions may be hindered, with Senator Chris Van Hollen highlighting a lack of congressional approval. The merger of the Drug Enforcement Administration and Bureau of Alcohol, Tobacco, Firearms, and Explosives was initially part of the plan but faced bipartisan resistance. Notably, the adjustments follow Trump's broader campaign to reshape federal government roles and priorities.
ALSO READ
Trump Administration Cuts $8 Billion in Climate Funding
Trump Administration's Bold Moves: Pharmaceutical Giants and Economic Revamp
Trump Administration Expands Foreign Aid Restrictions
Pfizer Agrees to Cut Drug Prices in Medicaid Deal with Trump Administration
Court Rules Against Trump Administration's Visa Policy on Pro-Palestinian Advocacy